Hadassah

Galmed Pharma Names Hadassah’s Dr. Ran Oren as Chief Medical Officer

Friday, Aug 5 2016

Chief Medical Officer Dr. Ran Oren.

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development of a once-daily, oral therapy for the treatment of liver diseases, has named Prof. Ran Oren, head of the Hadassah Medical Organization’s Institute of Gastroenterology and Liver Disease, as its new Chief Medical Officer.

Having received his medical degree from the Hadassah-Hebrew University School of Medicine, as well as residency training in internal medicine, gastroenterology, and liver pathology at Hadassah, Prof. Oren also completed a fellowship in New York City, combining research at Albert Einstein College of Medicine and advanced clinical fellowship at the Liver Division of Mount Sinai Medical Center. In 2000, Dr. Oren established the Liver Unit at the Tel Aviv Sourasky Medical Center, where he also served as Chief of Medicine from 2008 to 2010. Dr. Oren concurrently served as the President of the Israeli Association for the Study of the Liver between 2007 and 2010.  In 2010, he became head of Hadassah’s Institute of Gastroenterology and Liver Disease.

A scientific collaborator of the late Prof. Tuvia Gilat, Co-founder of Galmed, Prof. Oren has served as a member of Galmed’s Scientific Advisory Board since 2014. Prof. Oren was the principal investigator of Aramchol's Phase IIa study, reports Allen Baharaff, Galmed's President and Chief Executive Officer, “and we are privileged that he has agreed to join Galmed and lead the clinical development of Aramchol."

Prof. Oren notes: "I am honored to continue the life work of Prof. Gilat, who was my mentor and friend for many years. I have been scientifically and clinically involved in the field of NAFLD (non-alcoholic fatty liver disease) since the early 2000’s. I view this position at Galmed as an exciting opportunity for me to contribute to a company that I have been following from concept to this exciting phase of advanced clinical studies, and I look forward to working with the Galmed team."

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Jun 20 2017

Send in the Clowns: A Hadassah UK Dispatch

This week Hadassah UK (HUK) brought in one of the Hadassah Medical Organization's best and more unusual, head medical clown David Barashi (DuSH).

READ MORE ›
alt_text

Friday, Jun 16 2017

Hadassah’s Director General Receives Honorary PhD from Cyprus Medical School

For sharing his knowledge and experience with senior officials in the Cyprus medical system, Prof. Zeev Rotstein, Director General of the Hadassah Medical Organization, was awarded an honorary PhD from the St. George University of London’s Medical Program at the University of Nicosia Medical School in Cyprus.

READ MORE ›
alt_text

Thursday, Jun 8 2017

Hadassah Doctors Discover Bullet
in 12-Year-Old’s Arm

Muhammad Baduan, age 12, had been experiencing pain in his arm on and off for months. Hadassah Hospital Ein Kerem Emergency Room physicians put an end to the boy’s pain when they solved the mystery: Muhammad had a 22-millimeter bullet hidden in that arm--a bullet that had been shot into the air as part of a post-wedding ceremony celebration.

READ MORE ›
alt_text

Monday, Jun 5 2017

Hadassah Cutting-Edge Neuropsychiatrist Keynotes Alzheimer’s Conference

“The key is to give medicines much earlier--before the brain material has been destroyed by Alzheimer’s disease,” Dr. Shahar Arzy, head of the Hadassah Medical Organization’s Computational Neuropsychiatry Laboratory, told his audience at the Alzheimer’s Foundation of America (AFA)’s New York Educational Conference on May 5, 2017.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More